Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

16.20EUR
15 Dec 2017
Change (% chg)

€0.20 (+1.25%)
Prev Close
€16.00
Open
€16.18
Day's High
€16.20
Day's Low
€15.89
Volume
50,620
Avg. Vol
83,167
52-wk High
€30.20
52-wk Low
€12.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 1.79 -0.947
Mar '17 0.00 -0.817
FY 2016 Dec '16 1.74 -1.433
Jun '16 2.40 -1.310
FY 2015 Dec '15 1.45 -1.205
Jun '15 1.47 -0.950
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 5 2.58 5.00 0.00 7.07
Year Ending Dec-18 5 6.80 17.00 0.00 18.57
Earnings (per share)
Quarter Ending Dec-17 1 -1.42 -1.42 -1.42 --
Quarter Ending Dec-18 1 -1.47 -1.47 -1.47 --
Year Ending Dec-17 5 -2.05 -1.42 -2.46 -2.38
Year Ending Dec-18 5 -1.90 -1.18 -3.16 -2.62
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta 0.86 0.85 0.88
Price to Sales (TTM) 80.61 100.68 5.40
Price to Book (MRQ) -- 13.50 5.38
Price to Tangible Book (MRQ) -- 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions -- 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -25.59 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -8.67 75.04 5.38
Sales - 5 Yr. Growth Rate 35.25 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.52 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -27.13 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate 81.34 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) -- 5.36 2.98
LT Debt to Equity (MRQ) -- 18.93 11.56
Total Debt to Equity (MRQ) -- 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -732.50 -- --
EBITD - 5 Yr. Avg -321.23 -261.13 15.24
Operating Margin (TTM) -736.87 -556.69 7.76
Operating Margin - 5 Yr. Avg. -331.17 -279.31 10.75
Pre-Tax Margin (TTM) -727.19 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -337.58 -279.05 11.17
Net Profit Margin (TTM) -727.87 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -337.31 -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,447 25,316,769 864,680,848
Net Income/Employee (TTM) -301,682 3,332,346 101,718,394
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) -- 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.77 11.00
Return on Assets - 5 Yr. Avg. -38.25 -0.26 12.43
Return on Investment (TTM) -- 2.36 14.46
Return on Investment - 5 Yr. Avg. -46.07 2.98 16.28
Return on Equity (TTM) -- 2.96 16.05
Return on Equity - 5 Yr. Avg. -51.29 6.41 17.51
  1 Year 3 Year 5 Year
Sales % 41.28 31.92 35.25
EPS (TTM) % -27.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.30 -12.52 42 53
13 Week -7.07 -10.79 82 60
26 Week -12.20 -15.88 80 69
52 Week 35.52 13.27 99 46
YTD 76.06 59.71 99 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.53%
# of Holders: 22
Total Shares Held: 7,627,317
3 Mo. Net Change: 3,813,318
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 2
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.